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have shown that superoxide formation at the ubiquinol oxidation
center of membrane-bound or purified cytochrome bc1 complex is
stimulated by the presence of oxidized ubiquinone when the
ubiquinol reduction center (Qi site) is blocked [1]. This indicated
that the electron is transferred onto oxygen from reduced cyto-
chrome bL via ubiquinone in a reverse reaction rather than during the
forward Q-cycle reaction. In intact rat heart mitochondria respiring
on succinate, inhibitors (malonate, diazoxide, TTFA, and atpenin A5)
of the succinate:ubiquinone oxidoreductase (complex II) stimulated
mitochondrial ROS production at the Q0 site of complex III under
conditions of oxidant-induced reduction; this stimulation was greatly
enhanced by uncoupling [2]. We conclude that cytochrome bc1
complex linked ROS production is promoted by a partially oxidized
rather than by a fully reduced ubiquinone pool. This mechanism of
ROS production by complex III offers a straightforward rationale of
how the redox state of the ubiquinone pool could play a central role
in mitochondrial redox signaling.
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Mitochondrial complex I plays a critical role in regulating
cellular energy generation and the production of reactive oxygen
species (ROS). Two catalytically and structurally distinct forms of
mitochondrial complex I have been characterised in enzyme
preparations in vitro: one is a fully catalytically competent, active
(A)-form and the other is a dormant, silent or de-activated (D)-
form. When deprived of substrate at physiological temperatures the
idle enzyme undergoes conversion into the D-form. This can
gradually convert back to the A-form in the presence of substrate
(NADH and ubiquinone) during slow turnover(s) of the enzyme. In
the D-form of complex I a critical cysteine-39 of the ND3 subunit
becomes exposed to the outside of the enzyme and is susceptible to
modification and inhibition by peroxynitrite, nitrosothiols or ROS.
This cysteine group is not accessible to any covalent modification in
the A-form. Using a cultured cell line we have shown that A-to-D
transition occurred during anaerobic incubation, when the respira-
tory chain was reduced. Accumulation of the D-form of complex
I may be protective because slow re-activation of the D-form may
reduce the burst of damaging ROS that occurs after reoxygenation.
We also demonstrated that re-activation of the D-form could be
prevented by prolonged incubation with endogenously-generated
nitric oxide (NO). It is possible, therefore, that in some circum-
stances NO-dependent formation of S-nitrosothiols or peroxynitrite
may lead to modification of complex I when it is in its D-form and
so impede its return to the active state. Indeed, accumulation of the
covalently modified D-form is likely to be responsible for the so-
called persistent inhibition of cellular respiration that occurs in the
presence of NO. The detrimental effect of such irreversible locking
of complex I in the D-form could be due to the fact that the
modified D-form of the enzyme generates ROS at a higher rate than
the A-form. Thus a combination of changes in mitochondrial ROS
production, a change in NAD/NADH ratio and a decline in the rate
of oxidative phosphorylation could lead to cellular death and might
be responsible for ischaemic damage as well as for the early stages
of neurodegeneration.
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Metformin (dimethylbiguanidine) is the most commonly used
drug for the treatment of type 2 non-insulin dependent diabetes
mellitus. The beneficial effects of the drug include a decrease in blood
glucose, without stimulating insulin secretion and a general im-
provement in peripheral insulin sensitivity. Additionally, treatment of
type 2 diabetes with metformin is associated with an overall
reduction in circulating lipids and body weight both leading to a
lower cardiovascular risk. Metformin action involves AMPK activation
although the metabolic consequences will vary in the different target
tissues. In white adipose tissue metformin-induced AMPK activation
stimulates catabolic pathways that results in the reduction of
triglyceride stores as reflected by the smaller size of the adipocytes.
Despite fifty years of research, the early steps of metformin action are
far from being elucidated. It is known that biguanidine derivatives
inhibit mitochondrial respiration and this effect is probably at the
basis of their antidiabetic action. There are data suggesting an
indirect effect of metformin and, thus, the existence of a cell-
signalling pathway targeted to the respiratory chain has been
proposed. The inhibition of respiration would be responsible of two
important events that would signal or initiate a shift in the cellular
metabolism: (1) a decrease in the ATP levels that could lead to AMPK
activation and (2) an increase in the production of superoxide by the
respiratory chain with the concomitant raise in the levels of reactive
oxygen and nitrogen species. We have investigated the early effects of
metformin on 3T3-L1 adipocytes. We have observed that metformin
rapidly inhibits cellular respiration that leads to an increase in
reactive oxygen species levels and to AMPK activation. UCP2 levels
raise as part of the antioxidant response of the cell, since the presence
of a superoxide scavenger blocks its induction. UCP2 mRNA levels are
unchanged and therefore the raise in protein levels must reflect an
increased mRNA translation. AMPK activation is rapid, is associated
with the expected decrease in fatty acid synthesis and does not
require either the induction of UCP2 or a drop in ATP levels.
Interestingly, metformin inhibits pyruvate oxidation but does not
prevent the oxidation of added fatty acids.
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